Buccal extended release technology, enabling systemic absorption through the oral cavity bypassing the GI. The technology inhance salivation enable the API dissolved in saliva. Extended release for up to 8 hours, day and night usage. Developing product for Parkinson and PTSD. Existing product for Xerostomia. Clinical trial for Gingivitis in progress.